Table 2

Mortality results2-151 for all operating segments of a petroleum company combined, by sex, 1964–94

Cause of death (ICD-8 codes)Men: observed/expected SMR (95% CI)Women: observed/expected SMR (95% CI)
All causes of death (000–999)6254/7284.07506/630.61
0.86 (0.84 to 0.88)2-150 0.80 (0.73 to 0.88)2-150
Endocrine, nutritional, and metabolic diseases (240–279)118/153.069/19.02
0.77 (0.64 to 0.92)2-150 0.47 (0.22 to 0.90)2-150
Circulatory diseases (390–458)3084/3403.74182/234.51
0.91 (0.87 to 0.94)2-150 0.78 (0.67 to 0.90)2-150
Respiratory diseases (460–519)455/578.9723/35.32
0.79 (0.72 to 0.86)2-150 0.65 (0.41 to 0.98)2-150
Digestive diseases (520–577)219/288.5924/26.32
0.76 (0.66 to 0.87)2-150 0.91 (0.58 to 1.36)
Accidents, poisonings, and violence (e800–e999)375/576.3028/55.07
0.65 (0.59 to 0.72)2-150 0.51 (0.34 to 0.74)2-150
Malignant neoplasms (140–209)1611/1804.57198/205.59
0.89 (0.85 to 0.94)2-150 0.96 (0.83 to 1.11)
 Oesophagus (150)42/43.933/1.95
0.96 (0.69 to 1.29)—
 Stomach (151)83/118.834/7.45
0.70 (0.56 to 0.87)2-150 0.54 (0.15 to 1.38)
 Large intestine, except rectum (153)183/172.7019/21.68
1.06 (0.91 to 1.22)0.88 (0.53 to 1.37)
 Rectum and rectosigmoid junction (154)55/63.383/5.03
0.87 (0.65 to 1.13)0.60 (0.12 to 1.74)
 Liver (155.0)12/15.782/1.01
0.76 (0.39 to 1.33)—
 Pancreas (157)82/95.616/9.22
0.86 (0.68 to 1.06)0.65 (0.24 to 1.42)
 Bronchus and lung (162.1)478/564.3534/30.98
0.85 (0.77 to 0.93)2-150 1.10 (0.76 to 1.53)
 Malignant melanoma (172)22/16.621/2.58
1.32 (0.83 to 2.00)—
 Breast (174)1/2.2151/48.79
—1.04 (0.78 to 1.37)
 Uterine cancer (180, 182.0)0/0.0010/9.85
—1.02 (0.49 to 1.87)
 Ovary, fallopian tube, and broad ligaments (183)0/0.0020/12.64
—1.58 (0.97 to 2.44)
 Prostate (185)176/178.100/0.00
0.99 (0.85 to 1.14)—
 Kidney (189.0–189.2)41/42.913/3.28
0.96 (0.69 to 1.30)—
 Bladder (188)46/56.343/2.16
0.82 (0.60 to 1.09)—
 Brain (malignant) (191)44/43.325/5.95
1.02 (0.74 to 1.36)0.84 (0.27 to 1.96)
 Brain neoplasms (all) (191, 225.0, 238.1)46/49.305/6.79
0.93 (0.68 to 1.24)0.74 (0.24 to 1.72)
All nervous system neoplasms (malignant, benign, and unspecified) (191, 192, 225, 238)52/53.916/7.61
0.96 (0.72 to 1.26)0.79 (0.29 to 1.72)
 Reticulum cell sarcoma (200.0)8/6.531/0.67
1.22 (0.53 to 2.41)—
 Lymphosarcoma (200.1)9/9.551/0.89
0.94 (0.43 to 1.79)—
 Hodgkin's disease (201)7/10.251/1.26
0.68 (0.28 to 1.41)—
 Non-Hodgkin's lymphoma (200, 202.0, 202.2)49/50.065/6.10
0.98 (0.72 to 1.29)0.82 (0.27 to 1.91)
 Multiple myeloma (203)30/27.142/2.80
1.10 (0.75 to 1.58)—
 Leukaemias (204–207)56/62.856/6.97
0.89 (0.67 to 1.16)0.86 (0.32 to 1.88)
  Acute non-lymphocytic leukaemia (205.0, 206.0, 207.2)23/15.000/2.20
1.53 (0.97 to 2.30)—
  Acute lymphoid leukaemia (204.0)1/3.160/0.50
——
  Chronic lymphoid leukaemia (204.1)9/13.491/0.80
0.67 (0.30 to 1.27)—
  Acute myeloid (myelomonocytic) leukaemia (205.0)19/13.760/2.05
1.38 (0.83 to 2.16)—
  Chronic myeloid leukaemia (205.1)6/7.001/0.96
0.86 (0.32 to 1.87)—
  Other leukaemias (204.9, 205.9, 206.1, 206.9, 207.0, 207.1, 207.9)17/24.134/2.49
0.70 (0.41 to 1.13)—
Benign neoplasms (210–228)7/5.161/0.99
1.36 (0.54 to 2.79)—
Amyotrophic lateral sclerosis (348.0)18/11.111/1.40
1.62 (0.96 to 2.56)—
Cerebrovasular disease (430–438)457/524.1649/54.21
0.87 (0.79 to 0.96)2-150 0.90 (0.67 to 1.20)
Acute myocardial infarction (410)1014/1231.3537/68.01
0.82 (0.77 to 0.88)2-150 0.54 (0.38 to 0.75)2-150
Diseases of arteries, arterioles, and capillaries (440–448)239/209.9117/13.85
1.14 (1.00 to 1.29)1.23 (0.72 to 1.96)
Aortic aneurysm (441)109/85.737/3.50
1.27 (1.04 to 1.53)2-150 2.00 (0.80 to 4.12)
Chronic obstructive pulmonary disease (519.3)113/152.286/7.03
0.74 (0.61 to 0.89)2-150 0.85 (0.31 to 1.86)
Cirrhosis (571)87/126.4112/9.88
0.69 (0.55 to 0.85)2-150 1.22 (0.63 to 2.12)
Suicide (e950–e959)97/149.0312/15.11
0.65 (0.53 to 0.79)2-150 0.79 (0.41 to 1.39)

  • ↵2-150 95% CI does not include 1.00.

  • ↵2-151 Expected deaths based on Canadian general population mortalities.